Minimally invasive liver surgery in a hepato-biliary unit: learning curve and indications

Felice Giuliante1, Francesco Ardito

  • 1Hepatobiliary Surgery Unit, Agostino Gemelli Hospital, Catholic University of the Sacred Heart, Largo Agostino Gemelli, 8, 00168, Rome, Italy, fgiuliante@rm.unicatt.it.

Updates in Surgery
|July 22, 2015
PubMed

Insights

Minimally invasive liver surgery (MILS) increased significantly in a high-volume center without altering indications for benign liver disease or resection types. This highlights the safe adoption of MILS for complex procedures.

Area of Science:

  • Hepatobiliary Surgery
  • Minimally Invasive Surgery
  • Laparoscopic Surgery

Background:

  • Operative indications and resection types are critical in minimally invasive liver surgery (MILS).
  • Surgeons' experience should not dictate the fundamental indications for MILS.
  • Defining MILS indications and learning curves is essential in high-volume centers.

Purpose of the Study:

  • To define the indications for MILS.
  • To evaluate the learning curve for MILS.
  • To assess changes in MILS adoption over time in a high-volume hepatobiliary surgery unit.

Main Methods:

  • Retrospective analysis of 993 liver resections performed between 2009 and 2014.
  • Comparison of MILS rates during the first two and last two years of the study period.
  • Analysis of indications for MILS, including benign and malignant diseases, and specific procedures like left lateral sectionectomy.

Main Results:

  • MILS constituted 8.2% (81/993) of all liver resections.
  • The proportion of MILS significantly increased over time (6.4% vs. 10.8%, p=0.042).
  • MILS for malignant disease significantly increased (3.2% vs. 7.5%, p<0.001), while indications for benign disease and left lateral sectionectomies remained stable.
  • Minimally invasive approach was used in 67.6% of left lateral sectionectomies.

Conclusions:

  • The proportion of MILS significantly increased in a high-volume hepatobiliary surgery unit over the study period.
  • This increase was achieved without altering surgical indications for benign liver disease or the types of resections performed.
  • MILS adoption for malignant disease saw a significant rise, indicating expanding applicability.

Related Concept Videos